Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study (Q28171078)
Jump to navigation
Jump to search
scientific article (publication date: October 2004)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study |
scientific article (publication date: October 2004) |
Statements
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study (English)
0 references
October 2004
0 references
25
0 references
20
0 references
1845-52
0 references